Johnson & Johnson vs The Procter & Gamble Company

Full side-by-side comparison — 2026

Updated automatically

JNJ

Price USD 272.67
P/E Ratio 41.5x
Div Yield 1.95%
Beta 0.20
Sector Health Care

PG

Price USD 169.08
P/E Ratio 25.5x
Div Yield 2.55%
Beta 0.36
Sector Consumer Defensive

Price Overview

Metric JNJ PG
Current Price 272.67 169.07
Previous Close 267.14 167.85

Valuation

Metric JNJ PG
Trailing P/E 41.48 25.51
Forward P/E 23.55 22.81
Price / Book 8.07 7.22
Price / Sales 6.62 4.46
EV / EBITDA 20.24 16.63

Dividends & Income

Metric JNJ PG
Dividend Yield 1.95% 2.55%
Dividend Rate (Annual) 5.28 4.32
5-Year Avg Yield 2.77% 2.40%
Payout Ratio 79.01% 64.18%

Risk & Financial Health

Metric JNJ PG
Beta (Volatility) 0.20 0.36
Debt / Equity 54.77 70.34
Quick Ratio 0.65 0.49
Current Ratio 1.02 0.72

Growth & Profitability

Metric JNJ PG
Revenue Growth 5.90% 4.00%
Earnings Growth -95.90% 0.80%
Return on Equity 20.02% 29.61%
Revenue / Share 41.25 37.75
Trailing EPS 6.59 6.64
Forward EPS 11.61 7.43

Analyst Targets

Metric JNJ PG
Analyst Mean Target 280.18 175.83
Analyst High Target 320.00 190.00
Analyst Low Target 190.00 151.00

Bottom Line: JNJ vs PG

The Procter & Gamble Company (PG) leads on 9 of 15 comparable metrics.

The Procter & Gamble Company has a higher Earnings Growth (0.80% vs -95.90%), which indicates profits are growing more quickly
Johnson & Johnson has a lower Beta (Volatility) (0.20 vs 0.36), which typically indicates less price volatility
The Procter & Gamble Company has a lower Trailing P/E (25.51 vs 41.48), which may indicate better relative value

This comparison is based on publicly available financial data and is for informational purposes only. It is not investment advice. Past performance does not guarantee future results.

JNJ Johnson & Johnson

Best for Conservative Investors
• Lower Beta (Volatility): 0.20
• Lower Debt / Equity: 54.77
• Higher Quick Ratio: 0.65

PG The Procter & Gamble Company

Best for Value Investors
• Lower Trailing P/E: 25.51
• Lower Forward P/E: 22.81
• Lower Price / Book: 7.22
Best for Income Investors
• Higher Dividend Yield: 2.55%
• Lower Payout Ratio: 64.18%
Best for Growth Investors
• Higher Earnings Growth: 0.80%
• Higher Return on Equity: 29.61%

Watch Out

JNJ's earnings declined 96% — declining profits may mean current valuation metrics (PE, payout ratio) are misleading.

Analyst Upside / Downside

JNJ
+2.8%
PG
+4.0%

Based on analyst mean price targets. Estimates are not guaranteed and may not reflect future performance.

About These Companies

Johnson & Johnson (JNJ)

Health Care · United States · NYQ

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in …

View JNJ details →

The Procter & Gamble Company (PG)

Consumer Defensive · United States · NYQ

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides …

View PG details →

Frequently Asked Questions

Which has a better dividend yield, JNJ or PG?
The Procter & Gamble Company currently has the higher dividend yield. Johnson & Johnson (JNJ) yields 1.95% while The Procter & Gamble Company (PG) yields 2.55%. Past dividends do not guarantee future payments.
Which is more volatile, JNJ or PG?
The Procter & Gamble Company is more volatile based on beta. Johnson & Johnson has a beta of 0.20 and The Procter & Gamble Company has a beta of 0.36. A beta above 1.0 means higher volatility than the overall market.
Which is cheaper by P/E ratio, JNJ or PG?
The Procter & Gamble Company has the lower trailing P/E ratio. Johnson & Johnson trades at 41.5x earnings while The Procter & Gamble Company trades at 25.5x. A lower P/E may suggest better relative value, but could also reflect lower growth expectations.
Which has more analyst upside, JNJ or PG?
Based on mean analyst price targets, The Procter & Gamble Company has more upside potential. Johnson & Johnson has +2.8% upside and The Procter & Gamble Company has +4.0% upside from current prices. Analyst estimates are not guaranteed.
Can I track both JNJ and PG in one portfolio?
Yes. AllInvestView lets you add both Johnson & Johnson and The Procter & Gamble Company to the same portfolio and monitor price changes, dividends, total return, and allocation — completely free.

Track JNJ and PG in Your Portfolio

Add both to AllInvestView and compare their real-time performance, dividends, and gain/loss side by side.

Start Free Portfolio